Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print

Collaborations & Alliances

Related Searches:

Filter by:

October 22, 2012
EMA approves commercial production for Actavis drug   Read More »
October 22, 2012
Picks up portfolio, new ADHD treatment   Read More »
October 22, 2012
Offers $36 mil. for Dutch service provider   Read More »
October 18, 2012
Will begin Phase I trials of CUDC-907   Read More »
October 17, 2012
Three-year pact covers safety assessment, development DMPK   Read More »
October 16, 2012
$5 mil. upfront for exclusive license for candidates   Read More »
October 15, 2012
Services team will work out of Beijing lab   Read More »
October 15, 2012
Finnish pact begins with Phase I   Read More »
October 12, 2012
Paladin Licenses MOXDU for Canadian Sales   Read More »
October 11, 2012
To provide formulation development for Astimex product   Read More »
October 9, 2012
To develop treatments for hematological malignancies and solid tumors   Read More »
October 9, 2012
Bowsher to serve as senior research advisor   Read More »
October 9, 2012
To develop small molecule inhibitor against aggressive tumors   Read More »
October 5, 2012
Returns all rights, amends R&D pact   Read More »
October 4, 2012
Will explore SDD solutions for oral drugs   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On